Cantor biotech/biopharma analysts maintain an analyst/trade convention name
Biopharma/Biotech Analysts Chen & Kim and Biotech Analyst Kluska, together with KOL audio system Dr. Dahiya, Asssoc Prof at College of Maryland and Dr. Ruella, Asst Prof at College of Pennsylvania talk about how next-generation CAR-T therapies may broaden the market alternative for these firms’ therapies, together with NVS, GILD, BMY, JNJ, GRCL, PSTX, PGEN, MBIO, ACLX, ALLO, FATE and HARP on an Analyst/Trade convention name to be held on December 14 at 1 pm. Webcast Hyperlink
Printed first on TheFly
See the highest shares really helpful by analysts >>
Learn Extra on NVS:
